Minghui Pharmaceutical (hangzhou) Ltd

This study is testing an experimental drug called MHB039A in people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and effective. About 196 participants will receive the drug, and researchers will monitor side eff…

This study tests an ointment called MH004 in 156 people aged 12 to 65 with non-segmental vitiligo, a condition that causes white patches on the skin. The goal is to see if the ointment can safely help bring back skin color, especially on the face. Participants apply the cream for…

This study tests a new drug called MHB036C in 200 adults with advanced solid tumors that have not responded to other treatments. The goal is to find a safe dose and see if the drug can shrink tumors or slow their growth. Participants will be closely monitored for side effects.